We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$4.18B
AUM Growth
+$127M
Cap. Flow
-$138M
Cap. Flow %
-3.31%
Top 10 Hldgs %
18.27%
Holding
674
New
213
Increased
109
Reduced
103
Closed
236

Top Buys

Rank Stock Value
1
EA icon
Electronic Arts
EA
+$117M
2
BRBR icon
BellRing Brands
BRBR
+$64.8M
3
OMC icon
Omnicom Group
OMC
+$43.4M
4
GMED icon
Globus Medical
GMED
+$40.8M
5
CSX icon
CSX Corp
CSX
+$35.2M

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$96M
2
SMG icon
ScottsMiracle-Gro
SMG
+$44.3M
3
SHOP icon
Shopify
SHOP
+$41.9M
4
CNK icon
Cinemark Holdings
CNK
+$41M
5
CARR icon
Carrier Global
CARR
+$36.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.13%
2 Industrials 13.12%
3 Healthcare 9.89%
4 Communication Services 9.48%
5 Technology 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IJR icon
326
PUT
iShares Core S&P Small-Cap ETF
IJR
$109B
$1.22M 0.03%
11,200
-163,800
-94% -$16.9M
CAL icon
327
CALL
Caleres
CAL
$431M
$1.22M 0.03%
100,000
-651,000
-87% -$9.76M
IBTA icon
328
Ibotta
IBTA
$559M
$1.22M 0.03%
+33,336
New +$1.56M
SBGI icon
329
CALL
Sinclair Inc
SBGI
$992M
$1.21M 0.03%
+87,500
New +$1.24M
SBGI icon
330
Sinclair Inc
SBGI
$992M
$1.15M 0.03%
+83,001
New +$1.18M
TGTX icon
331
TG Therapeutics
TGTX
$7.96B
$1.12M 0.03%
31,250
+23,214
+289% +$864K
CYTK icon
332
Cytokinetics
CYTK
$10.5B
$1.11M 0.03%
+33,636
New +$1.17M
SPOT icon
333
Spotify
SPOT
$103B
$1.08M 0.03%
1,410
-1,154
-45% -$741K
MDGL icon
334
Madrigal Pharmaceuticals
MDGL
$10.8B
$1.07M 0.03%
3,551
-6,325
-64% -$1.88M
VRNA
335
DELISTED
Verona Pharma
VRNA
$1.07M 0.03%
11,318
-31,680
-74% -$2.35M
GPN icon
336
PUT
Global Payments
GPN
$23B
$1.04M 0.02%
+13,000
New +$1.03M
EWS icon
337
iShares MSCI Singapore ETF
EWS
$1.04B
$1.04M 0.02%
+40,000
New +$987K
SSP icon
338
CALL
E.W. Scripps
SSP
$257M
$989K 0.02%
+336,500
New +$813K
CORZ icon
339
Core Scientific
CORZ
$6.66B
$975K 0.02%
57,093
-1,218,419
-96% -$12.2M
YOU icon
340
CALL
Clear Secure
YOU
$5.57B
$972K 0.02%
+35,000
New +$892K
ARDX icon
341
Ardelyx
ARDX
$1.22B
$964K 0.02%
+245,917
New +$1.01M
ZVRA icon
342
Zevra Therapeutics
ZVRA
$562M
$951K 0.02%
108,000
-381,647
-78% -$3.1M
ETNB
343
DELISTED
89bio
ETNB
$946K 0.02%
96,339
-46,226
-32% -$383K
EVC icon
344
CALL
Entravision Communication
EVC
$1.03B
$889K 0.02%
+383,100
New +$773K
APGE icon
345
PUT
Apogee Therapeutics
APGE
$10.1B
$869K 0.02%
+20,000
New +$761K
RUN icon
346
PUT
Sunrun
RUN
$2.34B
$818K 0.02%
+100,000
New +$786K
NCMI icon
347
National CineMedia
NCMI
$376M
$810K 0.02%
+167,200
New +$907K
BDTX icon
348
Black Diamond Therapeutics
BDTX
$96.8M
$804K 0.02%
323,999
+67,500
+26% +$130K
CAL icon
349
Caleres
CAL
$431M
$799K 0.02%
65,363
-721,858
-92% -$10.8M
RL icon
350
Ralph Lauren
RL
$22.6B
$781K 0.02%
2,847
-44,101
-94% -$10.9M
12 13
14
15 16

Similar funds

CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $3.44B AUM 9.15% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return
DAM
Davis Asset Management Sausalito, California $3.46B AUM 9.77% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

J. Goldman & Co's Q2 2025 Portfolio in Review

As of Q2 2025, J. Goldman & Co held 674 positions worth $4.18B, up 3.1% from $4.05B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

J. Goldman & Co withdrew a net $138M in Q2 2025, closing 236 positions and reducing 103 holdings. Its most notable exit was ScottsMiracle-Gro, an estimated $44.3M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, J. Goldman & Co opened a new position in BellRing Brands worth $56.2M.

  • J. Goldman & Co's largest Q2 2025 buy was BellRing Brands: 970,558 shares worth $56.2M.
  • J. Goldman & Co added most to Electronic Arts in Q2 2025, an estimated $117M increase.
  • J. Goldman & Co's biggest Q2 2025 reduction was Mastercard, cutting an estimated $96M.
  • J. Goldman & Co fully exited ScottsMiracle-Gro in Q2 2025, selling an estimated $44.3M.
  • J. Goldman & Co's ten largest holdings make up 18% of its $4.18B portfolio in Q2 2025.
  • J. Goldman & Co opened 213 new positions and closed 236 in Q2 2025.
  • J. Goldman & Co's portfolio value rose 3.1% quarter-over-quarter to $4.18B.

Based on J. Goldman & Co's 13F filing for Q2 2025, filed 14 Aug 2025.